Genmab is a biotechnology company dedicated to developing antibody products and pioneering antibody medicines that address cancer treatment and serious diseases. The company focuses on creating groundbreaking KYSO (knock-your-socks-off) antibody therapeutics designed to change patients' lives and transform the future of treatment. Genmab operates as an innovative, science-rooted organization with a global presence, managing both partnered and fully owned commercial products across multiple markets. The company emphasizes a workplace culture where employees are compassionate, candid, and impact-driven, supporting their mission through technical operations, clinical development, and manufacturing partnerships.
Beta · Sourced from candidate reports
Be the first to share your experience with Genmab.
Your reply helps other candidates know what to expect.
